TR200101476T2 - N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması - Google Patents

N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması

Info

Publication number
TR200101476T2
TR200101476T2 TR2001/01476T TR200101476T TR200101476T2 TR 200101476 T2 TR200101476 T2 TR 200101476T2 TR 2001/01476 T TR2001/01476 T TR 2001/01476T TR 200101476 T TR200101476 T TR 200101476T TR 200101476 T2 TR200101476 T2 TR 200101476T2
Authority
TR
Turkey
Prior art keywords
substituted
nervous system
derivatives
central nervous
azabicycloacane
Prior art date
Application number
TR2001/01476T
Other languages
English (en)
Inventor
Munschauer Rainer
Steiner Gerd
Gross Gerhard
Traut Martin
Unger Liliane
Teschendorf Hans-J�Rgen
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of TR200101476T2 publication Critical patent/TR200101476T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)

Abstract

Formül I'in N-ikameli 3-azabisikloalkan türevlerinin öyle ki burada B, R1, R2 ve n tarifnamede tanimlandiklari gibidir, bagimlilik bozukluklarinin ve merkezi sinir sisteminin baska bozukluklarinin kontrol edilmesi için kullanilmasi tarif edilir.
TR2001/01476T 1998-11-24 1999-11-12 N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması TR200101476T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht

Publications (1)

Publication Number Publication Date
TR200101476T2 true TR200101476T2 (tr) 2001-10-22

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01476T TR200101476T2 (tr) 1998-11-24 1999-11-12 N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması

Country Status (21)

Country Link
EP (1) EP1133293A1 (tr)
JP (1) JP2002530333A (tr)
KR (1) KR20010080535A (tr)
CN (1) CN1328455A (tr)
AR (1) AR021502A1 (tr)
AU (1) AU1775300A (tr)
BG (1) BG105549A (tr)
BR (1) BR9915589A (tr)
CA (1) CA2352526A1 (tr)
CZ (1) CZ20011796A3 (tr)
DE (1) DE19854147A1 (tr)
HK (1) HK1040933A1 (tr)
HR (1) HRP20010472A2 (tr)
HU (1) HUP0104416A3 (tr)
IL (1) IL143181A0 (tr)
NO (1) NO20012538L (tr)
PL (1) PL348758A1 (tr)
SK (1) SK7112001A3 (tr)
TR (1) TR200101476T2 (tr)
WO (1) WO2000030639A1 (tr)
ZA (1) ZA200103976B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519013A2 (pt) 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
MX2015009153A (es) * 2013-01-15 2016-03-04 Novartis Ag Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
EP1133293A1 (de) 2001-09-19
DE19854147A1 (de) 2000-05-25
CN1328455A (zh) 2001-12-26
NO20012538D0 (no) 2001-05-23
SK7112001A3 (en) 2001-12-03
BR9915589A (pt) 2001-08-07
HRP20010472A2 (en) 2003-04-30
BG105549A (en) 2001-12-29
ZA200103976B (en) 2002-05-16
IL143181A0 (en) 2002-04-21
KR20010080535A (ko) 2001-08-22
HK1040933A1 (zh) 2002-06-28
AR021502A1 (es) 2002-07-24
AU1775300A (en) 2000-06-13
HUP0104416A2 (hu) 2002-04-29
CZ20011796A3 (cs) 2002-05-15
WO2000030639A1 (de) 2000-06-02
CA2352526A1 (en) 2000-06-02
PL348758A1 (en) 2002-06-03
HUP0104416A3 (en) 2002-11-28
NO20012538L (no) 2001-07-04
JP2002530333A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
DK0725779T3 (da) Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
MY131298A (en) 5-heteroyl indole derivatives
TR199901172T2 (tr) Yeni ikame edilmis pirazol türevleri.
EA199800772A1 (ru) Производные 6-фенилпиридил-2-амина
MY121294A (en) Novel hexanoic acid derivatives.
BR9408450A (pt) Antagonistas da neuroquinina diazabiciclicos
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
NO991974D0 (no) 5-HT1F agonister
NO970162D0 (no) Substituerte pyrimidinforbindelser og anvendelse derav
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
DE69530988T2 (de) Benzimidazolderivate mit dopaminerger wirkung
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
TR199900087T2 (tr) Alfo-amino asit amitleri, bunlarin hazirlanmasi ve terapik kullanimlari.
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
TR200101476T2 (tr) N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
BR9909878A (pt) 10-canfosulfonato de paroxetina para tratamento de distúrbios do sistema nervoso central
TR200000916T2 (tr) İkameli piperidin türevleri.
NO970498L (no) Benzimidazolderivater med dopaminergisk aktivitet